Jiya Desai


The Impact of a Social Media–Based Educational Intervention to Promote Training in Social Determinants of Health Among Medical Residents

Social determinants of health are conditions that people are born into and live under that affect their health, and can greatly impact clinical outcomes as well as contribute to health disparities and inequalities.

Claudene J. George, MD


Digital Health Tool Offers Innovative Quantitative Fall Assessment Solution for Older Adults

Falls cost the US more than $50 billion annually, but platforms like CatchU, a transformative digital health tool, provide quantitative fall assessment that might significantly enhance the current standard of care for predicting falls.

Jeffrey Dunn, MD


Tools and Resources for the Management of MS

Drs Jeffrey Dunn and Regina Berkovich review available tools and resources for the care of patients with multiple sclerosis, focusing on specific symptoms.

Larry Hanover


Tapping Into the Potential of Cell and Gene Therapy

Advancements in gene therapy approaches have opened the door for a glimpse into the future of care for a number of diseases.

Brandon Giglio, MD


Educating the Public on the Common Risk Factors for Stroke Awareness: Brandon Giglio, MD

The director of vascular neurology at NYU Langone Hospital in Brooklyn discussed the high prevalence of common risk factors for stroke, emphasizing the importance of early detection and management for prevention. [WATCH TIME: 4 minutes]

Tom Leist, MD


New Horizons in Multiple Sclerosis

Experts share insights on the latest innovations in multiple sclerosis research, in highlights from a recent State of the Science SummitTM, presented by Neurology Live®.

Tracy Salazar, PhD


Role of Advocacy Organizations in Seizure Action Plans, Seizure Education

A roundtable discussion featuring Scott Perry, MD, Orrin Devinsky, MD, and Tracy Salazar, PhD, details how advocacy organizations can help guide patients with epilepsy and their caregivers with a seizure action plan.

Ashgan Elshinawy, DO


Resources for Sleep Disorders

Drs C. Michael Gibson, Ashgan A. Elshinawy, and Nathaniel F. Watson share resources for the treatment of sleep disorders.

Mitzi Williams, MD


Key Points for the Management of Multiple Sclerosis

Stephen Krieger, MD; Daniel Bandari, MD, MS; Bruce Hughes, MD; Mitzi Williams, MD; and Heidi Crayton, MD, provide key takeaways for the treatment of patients with multiple sclerosis.

Jiwon Oh, MD, PhD


CMSC Live: 2024 Annual Meeting Day 1

Host Jeffrey Wilken, PhD, chats with Robert Naismith, MD; Jiwon Oh, MD, PhD; and Anthony Traboulsee, MD, about the first day of the 2024 CMSC Annual Meeting in Nashville, Tennessee.

Fred Lado, MD, PhD


Reviewing Updated Epilepsy Guidelines to Prioritize Outpatient Focus and Patient-Centric Approach: Fred Lado, MD, PhD

The professor of neurology at the Zucker School of Medicine at Hofstra-Northwell talked about recently updated epilepsy care guidelines that shift the focus to outpatient care, incorporating broader aspects like care coordination, medication access, and patient-identified needs. [WATCH TIME: 5 minutes]

Yinan Zhang, MD


The Intricate Relationship Between Biological Aging and Multiple Sclerosis: Yinan Zhang, MD

The assistant professor of neurology at The Ohio State University Wexner Medical Center talked about results from an ongoing study assessing biological aging in patients with multiple sclerosis using epigenetic clocks and p16INK4a. [WATCH TIME: 6 minutes]

John W. Day, MD, PhD


Advancements and Challenges in Genetic Treatments for Neuromuscular Diseases: John W. Day, MD, PhD

Ahead of the 2024 MDA Conference, the medical advisor and care center director at Muscular Dystrophy Association talked about the track sessions he will be cochairing at the meeting. [WATCH TIME: 5 minutes]

Douglas Kerr, MD


Role of Advocacy Organizations in Creating Safe Spaces for Rare Disorders

A panel of neurology experts detailed the importance that community leadership and creating a positive environment can do for patients with rare neurologic disorders [WATCH TIME: 5 minutes]

Amber Salter, MPH, PhD


How COViMS Registry Is Clarifying MS COVID-19 Risks: Amber Salter, MPH, PhD

The assistant professor of biostatistics at Washington University in St. Louis discussed what role the COViMS registry can play for the MS community at this stage in the pandemic.

Asya Wallach, MD


MS Biomarkers: Overview of Current and Emerging Markers

This article reviews emerging MRI, OCT, CSF, and blood biomarkers, highlighting their potential roles in improving MS patient management and prognosis.

Aaron Ritter, MD


Future of Treating Parkinson Disease Psychosis, Overcoming Challenges in Clinical Trials: Aaron Ritter, MD

The director of the Memory & Cognitive Disorders Clinic at Hoag Neuroscience Institute provided perspective on the difficulties with testing agents for Parkinson disease psychosis, and the future outlook of treating the symptom. [WATCH TIME: 4 minutes]

Smathorn Thakolwiboon, MD


Unravel the Mysteries of Multiple Sclerosis Mimics

Despite the diagnosis of MS improving, misdiagnosis remains a challenge, pointing to the need for proper differential diagnosis and mimic identification.

Federica Picariello, PhD


Digital Treatment Approach May Help Reduce Healthcare Burden for MS Fatigue: Federica Picariello, PhD

The postdoctoral researcher and health psychologist at King's College London spoke at ECTRIMS 2022 about the digital approach to treating fatigue in multiple sclerosis and the lack of available measurements. [WATCH TIME: 3 minutes]

Sarah C. Stoney, MSW, LSW


Examining Depression and Suicidality in Pediatric Patients With MS: Sarah C. Stoney, MSW, LSW

The social worker in the Pediatric Multiple Sclerosis Clinic at Children's Hospital of Philadelphia talked about depression and suicidality rates in pediatric patients with multiple sclerosis. [WATCH TIME: 5 minutes]

Anaya Mitchell


Unseen Battles: Advocacy and Community in the Face of Myasthenia Gravis

Anaya, a young woman with myasthenia gravis, discusses her challenges and triumphs living with a rare disease. She shares her personal story of advocacy and community, finding strength in the disease's impact on her independence and identity.

William Gallentine, DO


New Frontiers in the Prevention of Seizures, Gene Therapy in Epilepsy: William Gallentine, DO

The interim chief of pediatric neurology at Stanford Medicine Children’s Health discussed progress in preventing seizures among patients with epilepsy, the potential for gene-targeted therapies, and the importance of localizing where seizures are coming from. [WATCH TIME: 5 minutes]

Paul Strumph, MD


Bidirectionality of the Relaunched Myasthenia Gravis Patient Registry: Paul Strumph, MD

The lead of the Myasthenia Gravis Foundation of America Global Myasthenia Gravis Patient Registry spoke on 2 additional attributes of the patient registry. [WATCH TIME: 3 minutes]

Gloria von Geldern, MD


Multiple Sclerosis Care During a Pandemic

Join Ahmed Obeidat, MD, PhD; Anne Cross, MD; and Gloria von Geldern, MD, for the third program in this series, where they offer insight from neurology specialists on applying lessons learned from the COVID-19 pandemic into clinical practice when managing patients with multiple sclerosis.

Calaneet Balas, MSc, MBA


Addressing the Greatest Needs in ALS: Calaneet Balas, MSc, MBA

The president and chief executive officer of The ALS Association provided insight on the most pressing needs for patients with ALS and the organization’s focus going forward. [WATCH TIME: 5 minutes]

Douglas Sproule, MD, MSc


Raising Awareness to Improve Early Diagnosis and Treatment of Duchenne Muscular Dystrophy: Douglas Sproule, MD, MSc

The chief medical officer at ML Bio Solutions, an affiliate of BridgeBio, talked about the importance of awareness for neuromuscular diseases such as Duchenne muscular dystrophy and why a timely diagnosis can make a profound difference in a patient’s life. [WATCH TIME: 3 minutes]

David Shprecher, DO, MSci, FAAN


Advances in Minimally Invasive Diagnostic Tests for Neurodegenerative Diseases: David Shprecher, DO, MSci, FAAN

The director of movement disorders at the Banner Sun Health Research Institute talked about making strides in developing minimally invasive tests and imaging ligands for neurodegenerative diseases, such as Parkinson disease. [WATCH TIME: 2 minutes]

Christian Meisel, MD


Christian Meisel, MD, PhD: Treatment Landscape for Seizure Forecasting Devices

The neurologist from Universitätsmedizin Berlin and Berlin Institute of Health provided his insight on the reasons for the limited number of FDA-approved seizure forecasting devices.

© 2024 MJH Life Sciences

All rights reserved.